Author: News Room
Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Paraganglioma Market Report 2026” has been added to ResearchAndMarkets.com’s offering.The paraganglioma market is on an upward trajectory, with projections indicating a growth from $3.02 billion in 2025 to $3.76 billion by 2030, achieving a CAGR of 4.4%. This growth is propelled by advancements in biologic and immunotherapy drugs, a surge in autoimmune and infectious disorders, and innovative integrations like AI in diagnostics, teleophthalmology, and digital monitoring. These trends are reshaping the landscape of the paraganglioma market, enhancing diagnostic and treatment pathways. Investment influx in oncology research is a key driver, addressing the…
Introduction LAS VEGAS, March 30, 2026 (GLOBE NEWSWIRE) — EverForward Trading has announced a significant achievement as Brian Ferdinand, Portfolio Manager and Trader at the firm, has been selected to join the prestigious Forbes Finance Council. This invitation-only community, curated by Forbes, brings together some of the most accomplished leaders in the global financial industry. Ferdinand’s inclusion marks an important milestone not only in his professional journey but also in the continued growth and recognition of EverForward Trading. About the Forbes Finance Council The Forbes Finance Council is widely regarded as a leading network of senior-level finance executives, investors, and industry…
Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Neuroblastoma Market Report 2026” has been added to ResearchAndMarkets.com’s offering.The neuroblastoma market has witnessed significant growth, projected to expand from $3.14 billion in 2025 to $3.32 billion in 2026, with a CAGR of 5.8%. Factors driving this growth include an increase in pediatric neuroblastoma cases and advancements in treatment modalities, including chemotherapy and immunotherapy vaccines. Clinical diagnostic capabilities have also improved, leading to better early detection and heightened awareness of childhood cancer symptoms. Looking ahead, the neuroblastoma market is set to continue its upward trajectory, reaching $4.12 billion by 2030 at a…
Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Non-Muscle Invasive Bladder Cancer Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The non-muscle invasive bladder cancer (NMIBC) market size has experienced robust growth, increasing from $3.66 billion in 2025 to an anticipated $4.82 billion by 2030. This expansion is driven by factors such as a rise in early diagnosis, enhanced use of transurethral resection, and increased adoption of immunotherapy and chemotherapy. Improvements in hospital pharmacy infrastructure and the development of online and retail pharmacy channels have also contributed significantly. Personalized medicine is playing a crucial role in steering NMIBC market…
Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Cancer Supportive Care Products Market Report 2026” has been added to ResearchAndMarkets.com’s offering. This report offers valuable insights into global market size, regional shares, competitive analysis, and emerging trends, delivering an in-depth perspective critical for thriving in the cancer supportive care products industry. The global cancer supportive care products market is steadily evolving, with an anticipated growth from $22.47 billion in 2025 to $23.54 billion in 2026 at a CAGR of 4.8%. Historical growth is driven by increasing global cancer prevalence, rising chemotherapy and radiation therapy applications, and a higher incidence of…
Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Chemotherapy At Home Services Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The report offers a comprehensive analysis, detailing industry size, trends, and opportunities. The report provides tactical insights into current and future scenarios, supporting stakeholder strategies for navigating the evolving landscape. The chemotherapy-at-home services market is experiencing rapid growth, with an anticipated increase from $1.94 billion in 2025 to $2.16 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.1%. This expansion is supported by the development of outpatient cancer treatment programs, heightened demand for patient-centric care, and…
Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “AI in Oncology for Analytical Solutions Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The AI in oncology for analytical solutions market has seen remarkable growth in recent years, with its size increasing significantly. Projected to grow from $1.44 billion in 2025 to $1.93 billion in 2026 at a CAGR of 34.2%, and reaching $6.26 billion by 2030, the expansion can be linked to advancements in AI applications within the oncology field. Key factors fueling this growth include the enhancement of AI algorithms tailored for oncology, the integration of genomic data,…
Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Non-Small Cell Lung Cancer (NSCLC) Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The non-small cell lung cancer (NSCLC) market is witnessing robust expansion, projected to grow from $42.2 billion in 2025 to $46.65 billion in 2026, with a CAGR of 10.5%. This growth is historically attributed to factors such as widespread smoking, air pollution exposure, and a lack of targeted therapies, alongside dependence on conventional chemotherapy. By 2030, the market is further anticipated to reach $70.81 billion, spurred by the progressive adoption of innovative treatments and diagnostics. The forecast period…
Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Oncology Biomarkers Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights into market statistics, size, regional shares, competitors, trends, and opportunities crucial for thriving in this industry. The oncology biomarkers market is witnessing significant growth. Projected to expand from $17.3 billion in 2025 to $19.73 billion in 2026, the market is set to achieve a compound annual growth rate (CAGR) of 14.1%. This surge is due to the expansion of cancer screening programs, advancements in molecular biology research, increased availability of biomarker testing platforms, and a rise…
Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Companion Animal Health Market Size, Share & Trends Analysis Report by Animal, Product, Distribution Channel, End-use, Region, and Segment Forecasts, 2026-2033” has been added to ResearchAndMarkets.com’s offering. The global companion animal health market, initially valued at USD 25.46 billion in 2025, is on a trajectory to soar to USD 56.41 billion by 2033, driven by a robust CAGR of 10.6% from 2026 to 2033. Key growth factors include rapid advancements in companion animal health, increased zoonotic disease transfers from pets, regulatory changes, and enhanced R&D and procedural innovations. Innovation in therapeutics, diagnostics,…